Inhalationally Administered Semifluorinated Alkanes (SFAs) as Drug Carriers in an Experimental Model of Acute Respiratory Distress Syndrome
Sign Up to like & getrecommendations! Published in 2021 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics13030431
Abstract: Aerosol therapy in patients suffering from acute respiratory distress syndrome (ARDS) has so far failed in improving patients’ outcomes. This might be because dependent lung areas cannot be reached by conventional aerosols. Due to their… read more here.
Keywords: distress syndrome; acute respiratory; semifluorinated alkanes; alkanes sfas ... See more keywords
Semifluorinated Alkanes as New Drug Carriers—An Overview of Potential Medical and Clinical Applications
Sign Up to like & getrecommendations! Published in 2023 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics15041211
Abstract: Fluorinated compounds have been used in clinical and biomedical applications for years. The newer class of semifluorinated alkanes (SFAs) has very interesting physicochemical properties including high gas solubility (e.g., for oxygen) and low surface tensions,… read more here.
Keywords: overview potential; semifluorinated alkanes; clinical applications; new drug ... See more keywords